Advanced kidney disease
نویسندگان
چکیده
منابع مشابه
The gut–kidney connection in advanced chronic kidney disease
Recent basic and clinical findings emphasize that chronic kidney disease (CKD) is a common disease of national significance in many developed countries. In Japan, 1 in 8 adults suffers from CKD, although less than 10% of people know the term “CKD”. CKD is asymptomatic and leads to development of endstage renal failure with hemodialysis and increased mortality. The main cause of mortality in pat...
متن کاملHypertension goals in advanced-stage kidney disease.
Hypertension confers higher cardiovascular (CV) risks in hemodialysis (HD) patients. There are no data to guide the level to which BP should be reduced or when and where to measure BP in such patients. Unlike BP guidelines to reduce CV risk in the general population, no uniform guidelines address the HD patient. This article focuses on when and how to measure BP and efforts to quantify this mea...
متن کاملObesity and Kidney Disease
The rise in the prevalence of chronic kidney disease (CKD) and an increase in the prevalence of obesity in parallel in the recent years is a great concern. CKD increases the rate of cardiovascular disease (CVD) and development of end-stage renal disease, and leads to premature death. Although no direct causality link between obesity and CKD can yet be established, this appears highly probable. ...
متن کامل[Study of oxidative stress in advanced kidney disease].
INTRODUCTION Introduction Patients with Chronic renal Disease (CRD) often have cardiovascular disease that is the main cause of morbidity and mortality. Oxidative stress and a subclinical inflammation are crucial factors in its development. The aim of this study was to asses the oxidation of the main molecular lines in patients with advanced renal disease without dialysis and to determinate the...
متن کاملFebuxostat for Hyperuricemia in Patients with Advanced Chronic Kidney Disease
Febuxostat is a nonpurine xanthine oxidase (XO) inhibitor, which recently received marketing approval. However, information regarding the experience with this agent among advanced chronic kidney disease (CKD) patients is limited. In the current study, we investigated the effects of oral febuxostat in patients with advanced CKD with asymptomatic hyperuricemia. We demonstrated, for the first time...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Nurse Practitioner
سال: 2020
ISSN: 0361-1817
DOI: 10.1097/01.npr.0000722304.42807.02